rs2066819
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_005419.4(STAT2):c.131+21G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0581 in 1,610,634 control chromosomes in the GnomAD database, including 3,110 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.046 ( 222 hom., cov: 31)
Exomes 𝑓: 0.059 ( 2888 hom. )
Consequence
STAT2
NM_005419.4 intron
NM_005419.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.805
Publications
38 publications found
Genes affected
STAT2 (HGNC:11363): (signal transducer and activator of transcription 2) The protein encoded by this gene is a member of the STAT protein family. In response to cytokines and growth factors, STAT family members are phosphorylated by the receptor associated kinases, and then form homo- or heterodimers that translocate to the cell nucleus where they act as transcription activators. In response to interferon (IFN), this protein forms a complex with STAT1 and IFN regulatory factor family protein p48 (ISGF3G), in which this protein acts as a transactivator, but lacks the ability to bind DNA directly. The protein mediates innate antiviral activity. Mutations in this gene result in Immunodeficiency 44. [provided by RefSeq, Aug 2020]
STAT2 Gene-Disease associations (from GenCC):
- primary immunodeficiency with post-measles-mumps-rubella vaccine viral infectionInheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, G2P
- pseudo-TORCH syndrome 3Inheritance: AR Classification: STRONG, LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0667 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0456 AC: 6935AN: 152144Hom.: 219 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
6935
AN:
152144
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0488 AC: 12168AN: 249138 AF XY: 0.0484 show subpopulations
GnomAD2 exomes
AF:
AC:
12168
AN:
249138
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0594 AC: 86611AN: 1458372Hom.: 2888 Cov.: 32 AF XY: 0.0589 AC XY: 42712AN XY: 725232 show subpopulations
GnomAD4 exome
AF:
AC:
86611
AN:
1458372
Hom.:
Cov.:
32
AF XY:
AC XY:
42712
AN XY:
725232
show subpopulations
African (AFR)
AF:
AC:
272
AN:
33326
American (AMR)
AF:
AC:
2344
AN:
44148
Ashkenazi Jewish (ASJ)
AF:
AC:
630
AN:
26022
East Asian (EAS)
AF:
AC:
1442
AN:
39670
South Asian (SAS)
AF:
AC:
1914
AN:
85764
European-Finnish (FIN)
AF:
AC:
2914
AN:
53378
Middle Eastern (MID)
AF:
AC:
89
AN:
5346
European-Non Finnish (NFE)
AF:
AC:
73780
AN:
1110490
Other (OTH)
AF:
AC:
3226
AN:
60228
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
4293
8586
12880
17173
21466
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
2680
5360
8040
10720
13400
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0456 AC: 6947AN: 152262Hom.: 222 Cov.: 31 AF XY: 0.0446 AC XY: 3320AN XY: 74450 show subpopulations
GnomAD4 genome
AF:
AC:
6947
AN:
152262
Hom.:
Cov.:
31
AF XY:
AC XY:
3320
AN XY:
74450
show subpopulations
African (AFR)
AF:
AC:
454
AN:
41554
American (AMR)
AF:
AC:
810
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
AC:
70
AN:
3472
East Asian (EAS)
AF:
AC:
176
AN:
5186
South Asian (SAS)
AF:
AC:
96
AN:
4830
European-Finnish (FIN)
AF:
AC:
569
AN:
10606
Middle Eastern (MID)
AF:
AC:
9
AN:
294
European-Non Finnish (NFE)
AF:
AC:
4649
AN:
67998
Other (OTH)
AF:
AC:
71
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
349
698
1047
1396
1745
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
86
172
258
344
430
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
231
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.